Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | BMY | AMGN | MRNA | GILD |
| Company | Clovis Oncology Inc | Bristol-Myers Squibb Company | Amgen Inc | Moderna Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0808 | 49.00 | 270.63 | 111.05 | 66.58 |
| High | 0.0977 | 49.05 | 274.86 | 111.29 | 67.19 |
| Low | 0.0766 | 48.55 | 269.65 | 106.64 | 66.37 |
| Last | 0.0812 | 48.92 | 273.79 | 109.06 | 66.86 |
| Change | -0.0048 | -0.07 | +0.25 | +1.17 | -0.17 |
| % Change | -5.58% | -0.14% | +0.09% | +1.08% | -0.25% |
| Volume | 24,516,400 | 11,934,142 | 1,202,457 | 2,580,301 | 4,626,724 |
| 20-Day Average Volume | 9,433,500 | 11,027,962 | 2,105,998 | 3,182,211 | 6,280,066 |
| Previous Close | 0.0860 | 48.99 | 273.54 | 107.89 | 67.03 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 50.37 | 271.60 | 105.19 | 69.06 |
| 20-Day Raw Stochastic | 1.73% | 18.15% | 47.59% | 59.87% | 12.61% |
| 20-Day Relative Strength | 23.83% | 41.15% | 49.11% | 55.92% | 32.46% |
| Weighted Alpha | -91.19 | -26.02 | +11.68 | -9.01 | -21.06 |
| Today's Opinion | 100% Sell | 88% Sell | 40% Sell | 88% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 40% Sell | 88% Buy | 100% Sell |
| Last Month's Opinion | 100% Sell | 8% Sell | 24% Buy | 72% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | +2.13% since 04/17/24 | +3.74% since 04/17/24 | +4.71% since 04/17/24 | -0.04% since 04/17/24 |
| Low | 0.0760 on 12/16/22 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 99.30 on 04/22/24 | 65.90 on 04/18/24 |
| High | 0.1439 on 12/14/22 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 111.19 on 04/24/24 | 67.68 on 04/23/24 |
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | -5.91% since 03/22/24 | -0.80% since 03/22/24 | +2.73% since 03/22/24 | -7.86% since 03/22/24 |
| Low | 0.0760 on 12/16/22 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 97.00 on 04/03/24 | 65.90 on 04/18/24 |
| High | 0.3772 on 12/01/22 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 115.89 on 04/09/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | -2.75% since 01/24/24 | -10.33% since 01/24/24 | +7.12% since 01/24/24 | -15.87% since 01/24/24 |
| Low | 0.0760 on 12/16/22 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 84.06 on 02/13/24 | 65.90 on 04/18/24 |
| High | 1.3100 on 10/04/22 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 115.89 on 04/09/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | -12.94% since 10/24/23 | -0.79% since 10/24/23 | +35.79% since 10/24/23 | -14.39% since 10/24/23 |
| Low | 0.0760 on 12/16/22 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 62.55 on 11/02/23 | 65.90 on 04/18/24 |
| High | 3.2500 on 07/08/22 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 115.97 on 01/08/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 99,290,928 | 146,720,288 | 41,308,924 | 83,457,512 |
| Shares Outstanding, K | 144,955 | 2,026,759 | 536,376 | 382,880 | 1,245,077 |
| Annual Sales | 148,760,000 | 45,006,000,000 | 28,190,000,000 | 6,848,000,000 | 27,116,000,000 |
| Annual Net Income | -264,520,000 | 8,025,000,000 | 6,717,000,000 | -4,714,000,000 | 5,665,000,000 |
| Last Quarter Sales | 30,660,000 | 11,477,000,000 | 8,196,000,000 | 2,811,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -56,010,000 | 1,762,000,000 | 767,000,000 | 217,000,000 | 1,429,000,000 |
| 60-Month Beta | 0.24 | 0.39 | 0.58 | 1.62 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.55 on 02/22/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 11/09/22 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | N/A | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.55 | 14.58 | 0.00 | 9.96 |